These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 23352754

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
    Grandane A, Tanc M, Zalubovskis R, Supuran CT.
    Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1256-60. PubMed ID: 24518190
    [Abstract] [Full Text] [Related]

  • 24. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
    Mollica A, Costante R, Akdemir A, Carradori S, Stefanucci A, Macedonio G, Ceruso M, Supuran CT.
    Bioorg Med Chem; 2015 Sep 01; 23(17):5311-8. PubMed ID: 26264840
    [Abstract] [Full Text] [Related]

  • 25. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Güzel-Akdemir Ö, Akdemir A, Karalı N, Supuran CT.
    Org Biomol Chem; 2015 Jun 21; 13(23):6493-9. PubMed ID: 25967275
    [Abstract] [Full Text] [Related]

  • 26. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J, Brzozowski Z, Żołnowska B, Szafrański K, Pogorzelska A, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Sep 12; 84():59-67. PubMed ID: 25016228
    [Abstract] [Full Text] [Related]

  • 27. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R, Agnello S, Ferro S, De Luca L, Vullo D, Brynda J, Mader P, Supuran CT, Chimirri A.
    J Med Chem; 2010 Mar 25; 53(6):2401-8. PubMed ID: 20170095
    [Abstract] [Full Text] [Related]

  • 28. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
    Nocentini A, Carta F, Ceruso M, Bartolucci G, Supuran CT.
    Bioorg Med Chem; 2015 Nov 01; 23(21):6955-66. PubMed ID: 26432607
    [Abstract] [Full Text] [Related]

  • 29. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS, Abdel-Aziz AA, Bua S, Nocentini A, AlSaif NA, Almehizia AA, Alanazi MM, Hefnawy MM, Supuran CT.
    Eur J Med Chem; 2019 Nov 01; 181():111573. PubMed ID: 31394463
    [Abstract] [Full Text] [Related]

  • 30. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
    Carradori S, Mollica A, Ceruso M, D'Ascenzio M, De Monte C, Chimenti P, Sabia R, Akdemir A, Supuran CT.
    Bioorg Med Chem; 2015 Jul 01; 23(13):2975-81. PubMed ID: 26007302
    [Abstract] [Full Text] [Related]

  • 31. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
    D'Ambrosio K, Vitale RM, Dogné JM, Masereel B, Innocenti A, Scozzafava A, De Simone G, Supuran CT.
    J Med Chem; 2008 Jun 12; 51(11):3230-7. PubMed ID: 18481843
    [Abstract] [Full Text] [Related]

  • 32. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA, Boone CD, Rife BD, Supuran CT, McKenna R.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7210-5. PubMed ID: 24090602
    [Abstract] [Full Text] [Related]

  • 33. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J, Pogorzelska A, Żołnowska B, Brożewicz K, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jul 23; 82():47-55. PubMed ID: 24871996
    [Abstract] [Full Text] [Related]

  • 34. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Nov 01; 14(21):5427-33. PubMed ID: 15454239
    [Abstract] [Full Text] [Related]

  • 35. 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII.
    Khloya P, Celik G, SitaRam, Vullo D, Supuran CT, Sharma PK.
    Eur J Med Chem; 2014 Apr 09; 76():284-90. PubMed ID: 24589484
    [Abstract] [Full Text] [Related]

  • 36. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS, Angapelly S, Angeli A, Digwal CS, Arifuddin M, Babu BN, Supuran CT, Kamal A.
    J Enzyme Inhib Med Chem; 2017 Dec 09; 32(1):1274-1281. PubMed ID: 28965419
    [Abstract] [Full Text] [Related]

  • 37. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z, Sławiński J, Innocenti A, Supuran CT.
    Eur J Med Chem; 2010 Sep 09; 45(9):3656-61. PubMed ID: 20554082
    [Abstract] [Full Text] [Related]

  • 38. New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.
    Rogez-Florent T, Meignan S, Foulon C, Six P, Gros A, Bal-Mahieu C, Supuran CT, Scozzafava A, Frédérick R, Masereel B, Depreux P, Lansiaux A, Goossens JF, Gluszok S, Goossens L.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1451-64. PubMed ID: 23168081
    [Abstract] [Full Text] [Related]

  • 39. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2359-64. PubMed ID: 15837325
    [Abstract] [Full Text] [Related]

  • 40. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
    Bozdag M, Alafeefy AM, Altamimi AM, Carta F, Supuran CT, Vullo D.
    Bioorg Med Chem; 2017 May 15; 25(10):2782-2788. PubMed ID: 28389112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.